WALNUT CREEK, Calif., Nov. 7, 2016 /PRNewswire/ -- Providence Medical Technology, Inc., an innovator in tissue-sparing cervical fusion technology, today announced the commercial launch of its new CAVUX Cervical Cage-L and DTRAX Spinal System-L.
The CAVUX Cervical Cage-L is an intervertebral cage made of solid titanium alloy with a large graft window and proprietary subtractive surface treatment technology. It is packaged sterile and supplied pre-loaded on a disposable delivery instrument. The DTRAX Spinal System-L is a single-use, disposable set of surgical instruments designed for cervical fusion and compatible with CAVUX Cervical Cage-L.
"I found the delivery of this new cage to be easier and more efficient than other options currently available for anterior cervical discectomy and fusion (ACDF)," said Dr. Kris Siemionow of the University of Illinois at Chicago after performing the first commercial use of the device. "The instruments in the new DTRAX Spinal System-L allowed me to deliver the device with fewer steps and in less time than the typical ACDF [procedure]," he added.
CAVUX Cervical Cage-L is indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine (C3-C7) with accompanying radicular symptoms at one disc level. Devices are intended to be used with autogenous bone graft and supplemental fixation, such as an anterior plating system.
Providence's family of products for cervical spine surgery now includes DTRAX Spinal Systems, CAVUX Cervical Cages, BIOLOGIX™ Allograft Bone, and ALLY™ Bone Screws.
"The launch of CAVUX Cervical Cage-L and DTRAX Spinal System-L represents an important step in broadening our platform of innovative, single-use instruments and implants for cervical fusion," commented Jeff Smith, Chief Executive Officer of Providence Medical Technology. "We are committed to filling critical gaps in the continuum of traditional cervical spine care."
About Providence Medical Technology, Inc.
Providence Medical Technology, Inc. is a privately-held medical device company developing innovative solutions addressing the $2 billion worldwide cervical spine market. The company is focused on commercializing the DTRAX platform of single-use, tissue-sparing instruments and CAVUX implants for cervical fusion, as well as other technologies that improve cervical spine procedures for both physicians and patients. For more information, visit www.providencemt.com.
DTRAX, CAVUX, BIOLOGIX, and ALLY are trademarks of Providence Medical Technology, Inc.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/providence-medical-technology-announces-the-launch-of-cavux-cervical-cage-l-and-dtrax-spinal-system-l-300358477.html
SOURCE Providence Medical Technology, Inc.